Vaccines

Details Vaccines Vaccines

C - Chemistry, Metallurgy

12

N

C12N 7/01 (2006.01) A61K 39/295 (2006.01) C07K 14/075 (2006.01) C07K 14/145 (2006.01) C12N 15/35 (2006.01) C12N 15/47 (2006.01) C12N 15/48 (2006.01) C12N 15/861 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2074502

A recombinant adenovirus acting as a vector for an antigen-producing gene (e.g. a rabies glycoprotein gene) comprises a CAV-2 strain modified to contain the promoter-gene sequence within the region from the SmaI site close to the end of the invert- ed terminal repeat up to the promoter for the early region 4 (E4). To assist replication the recombinant virus is transfected into a cell line expressing Ela proteins. The recombinant virus is used for the production of a corresponding vaccine.

Affiliated with

Also associated with

Rating

Vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2085893